Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide in Laparoscopic Hepatectomy: Effect on Blood Loss and Hemodynamic Support
2023-503613-29-00Phase 2Authorised
- Sponsor
- Clínica Universidad de Navarra
- Start
- Jun 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of octreotide in Liver lesion, sponsored by Clínica Universidad de Navarra. Primary endpoint: Intraoperative blood loss. Planned start Jun 2023; status: authorised.
02
Drugs
octreotide
03
Conditions
Liver lesion
Beyond the preview
Go deeper on 2023-503613-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503613-29-00.